TY - JOUR
T1 - Hypersensitivity pneumonitis
T2 - A perspective from members of the pulmonary pathology society
AU - Miller, Ross
AU - Allen, Timothy Craig
AU - Barrios, Roberto J.
AU - Beasley, Mary Beth
AU - Burke, Louise
AU - Cagle, Philip T.
AU - Capelozzi, Vera Luiza
AU - Ge, Yimin
AU - Hariri, Lida P.
AU - Kerr, Keith M.
AU - Khoor, Andras
AU - Larsen, Brandon T.
AU - Mark, Eugene J.
AU - Matsubara, Osamu
AU - Mehrad, Mitra
AU - Mino-Kenudson, Mari
AU - Raparia, Kirtee
AU - Roden, Anja Christiane
AU - Russell, Prudence
AU - Schneider, Frank
AU - Sholl, Lynette M.
AU - Smith, Maxwell Lawrence
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2018/1
Y1 - 2018/1
N2 - Context.-Hypersensitivity pneumonitis (HP) is a lung disease that develops in susceptible individuals after inhalational exposure to an organic antigen or chemical compound. Pathogenesis is attributed to a combination of type III (immune complex-mediated) and type IV (delayed) hypersensitivity reactions to the inciting agent. Objective.-To provide an overview of the current status of the medical literature regarding hypersensitivity pneumonitis. Data Sources.-A literature search was performed using PubMed and Google search engines. The terms "hypersensitivity pneumonitis" and "extrinsic allergic alveolitis" were used, with the search starting on January 9, 2017, and concluding March 8, 2017. Conclusions.-As a pathologist, it is important to consider hypersensitivity pneumonitis when examining lung specimens because it is often clinically and pathologically overlooked. Recognizing the often subtle findings and correlating them with the patient's history or suggesting a thorough clinical investigation of potential exposures can be of help in identifying the underlying condition so that the patient can be appropriately managed.
AB - Context.-Hypersensitivity pneumonitis (HP) is a lung disease that develops in susceptible individuals after inhalational exposure to an organic antigen or chemical compound. Pathogenesis is attributed to a combination of type III (immune complex-mediated) and type IV (delayed) hypersensitivity reactions to the inciting agent. Objective.-To provide an overview of the current status of the medical literature regarding hypersensitivity pneumonitis. Data Sources.-A literature search was performed using PubMed and Google search engines. The terms "hypersensitivity pneumonitis" and "extrinsic allergic alveolitis" were used, with the search starting on January 9, 2017, and concluding March 8, 2017. Conclusions.-As a pathologist, it is important to consider hypersensitivity pneumonitis when examining lung specimens because it is often clinically and pathologically overlooked. Recognizing the often subtle findings and correlating them with the patient's history or suggesting a thorough clinical investigation of potential exposures can be of help in identifying the underlying condition so that the patient can be appropriately managed.
UR - http://www.scopus.com/inward/record.url?scp=85039054815&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85039054815&partnerID=8YFLogxK
U2 - 10.5858/arpa.2017-0138-SA
DO - 10.5858/arpa.2017-0138-SA
M3 - Article
C2 - 28613913
AN - SCOPUS:85039054815
SN - 0003-9985
VL - 142
SP - 120
EP - 126
JO - Archives of Pathology and Laboratory Medicine
JF - Archives of Pathology and Laboratory Medicine
IS - 1
ER -